Tetraphase Pharmaceuticals announces closing of public offering of common stock
Tetraphase announced the closing of its underwritten public offering of 4,542,500 shares of common stock at an offering price of $19.00 per share. Gross proceeds were $86.3 million. BMO Capital Markets, Stifel and Guggenheim Securities are acting as joint bookrunning managers. October 22, 2014